Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis
European Heart Journal - Cardiovascular Pharmacotherapy · 14.08.2024 · 10 (5) · 444-453
DOI: 10.1093/ehjcvp/pvae042 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift European Heart Journal - Cardiovascular Pharmacotherapy, online erschienen am 06.06.2024. Verfasst von Paul M Haller und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Heart and Vascular Center Hamburg, Building O50, Empore, Martinistrasse 52, 20246 Hamburg, Germany. Hauptthemen laut MEDLINE: Thrombosis, Hemorrhage, Heart Diseases. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Aims
Direct oral anticoagulants (DOACs) are increasingly used off-label to treat patients with left ventricular thrombus (LVT). We analysed available meta-data comparing DOACs and vitamin K antagonists (VKAs) for efficacy and safety.
Methods
We conducted a systematic search and meta-analysis of observational and randomized data comparing DOACs vs. VKAs in patients with LVT. Endpoints of interest were stroke or systemic embolism, thrombus resolution, all-cause death, and a composite bleeding endpoint. Estimates were pooled using a random-effects model meta-analysis, and their robustness was investigated using sensitivity and influential analyses.
Results
We identified 22 articles (18 observational studies, 4 small randomized clinical trials) reporting on a total of 3587 patients (2489 VKA vs. 1098 DOAC therapy). The pooled estimates for stroke or systemic embolism [odds ratio (OR): 0.81; 95% confidence interval (CI): 0.57, 1.15] and thrombus resolution (OR: 1.12; 95% CI: 0.86, 1.46) were comparable, and there was low heterogeneity overall across the included studies. The use of DOACs was associated with lower odds of all-cause death (OR: 0.65; 95% CI: 0.46, 0.92) and a composite bleeding endpoint (OR: 0.67; 95% CI: 0.47, 0.97). A risk of bias was evident particularly for observational reports, with some publication bias suggested in funnel plots.
Conclusion
In this comprehensive analysis of mainly observational data, the use of DOACs was not associated with a significant difference in stroke or systemic embolism, or thrombus resolution, compared with VKA therapy. The use of DOACs was associated with a lower rate of all-cause death and fewer bleeding events. Adequately sized randomized clinical trials are needed to confirm these findings, which could allow a wider adoption of DOACs in patients with LVT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, University Heart and Vascular Center Hamburg, Building O50, Empore, Martinistrasse 52, 20246 Hamburg, Germany.
- German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck, Hamburg 20246, Germany.
- Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.
- Division of Clinical Science, Danderyd hospital, Karolinska Institute, Stockholm 171 77, Sweden.
- Department of Medical and Surgical Sciences, University of Bologna, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna 40126, Italy.
- Cardiovascular Institute, Azienda Ospedaliera Universitaria S. Anna, Ferrara 44124, Italy.
ORCID-Profile: Paul M Haller, Niema Kazem, Claudio Borghi, Dobromir Dobrev, Elisabetta Cerbai, Alexander Niessner, Bianca Rocca, Giuseppe Rosano, Renate B Schnabel, Patrick Sulzgruber
Zitieren
APA
Haller, P. M., Kazem, N., Agewall, S., Borghi, C., Ceconi, C., Dobrev, D., Cerbai, E., Grove, E. L., Kaski, J. C., Lewis, B. S., Niessner, A., Rocca, B., Rosano, G., Savarese, G., Schnabel, R. B., Semb, A. G., Sossalla, S., Wassmann, S., & Sulzgruber, P. (2024). Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis. European Heart Journal - Cardiovascular Pharmacotherapy, 10(5), 444-453. https://doi.org/10.1093/ehjcvp/pvae042
Vancouver
Haller PM, Kazem N, Agewall S, Borghi C, Ceconi C, Dobrev D, et al. Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis. European Heart Journal - Cardiovascular Pharmacotherapy. 2024;10(5):444-453. doi:10.1093/ehjcvp/pvae042
BibTeX
@article{Haller2024,
author = {Haller, Paul M and Kazem, Niema and Agewall, Stefan and Borghi, Claudio and Ceconi, Claudio and Dobrev, Dobromir and Cerbai, Elisabetta and Grove, Erik Lerkevang and Kaski, Juan Carlos and Lewis, Basil S and Niessner, Alexander and Rocca, Bianca and Rosano, Giuseppe and Savarese, Gianluigi and Schnabel, Renate B and Semb, Anne Grete and Sossalla, Samuel and Wassmann, Sven and Sulzgruber, Patrick},
title = {Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis},
journal = {European Heart Journal - Cardiovascular Pharmacotherapy},
year = {2024},
volume = {10},
number = {5},
pages = {444--453},
doi = {10.1093/ehjcvp/pvae042}
}
EUVIMED